Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Comprehensive characterization reveals sputum supernatant as a valuable alternative liquid biopsy for genome profiling in advanced non-small cell lung cancer

Fig. 1

Distribution of key quality control indices for detected genomic alterations from biopsy samples of tumor (TIS), sputum supernatant (SPU), and plasma (PLA). A Distribution of maximum allele frequencies (maxAFs) among the three types of biopsy samples. Copy number variations, gene fusions, and other large genomic rearrangements were excluded from maxAF calculation. B Distribution of insert sizes. ***, p < 0.001

Back to article page